CHIEF EXECUTIVE OFFICER, THRIVE EARLIER DETECTION CORP.
Cambridge, Massachusetts, United States
Dave Daly currently serves as the Chief Executive Officer and Board Member for Thrive Earlier Detection. Thrive is a healthcare company focused on incorporating earlier cancer detection into routine medical care to extend and save lives. The company is developing CancerSEEK, a liquid biopsy test that is designed to detect many cancers at earlier stages of disease that will serve as the core of its integrated cancer information offering. CancerSEEK is designed to be administered to healthy adults during routine medical care, such as a yearly checkup, alongside existing cancer screening tools. Dave has more than 30 years of experience in the diagnostics industry and most recently held senior leadership positions at Illumina and Foundation Medicine.
The liquid biopsy market is expected to grow to as much as $30 billion by 2025. Many factors are…